Estrogen Modulation of Mood and Cognition Following Monoaminergic Depletion in Post-Menopausal Women
2 other identifiers
interventional
N/A
1 country
1
Brief Summary
This study will examine whether estrogen administration in postmenopausal women can alter the response to changes in brain chemistry brought about by dietary manipulation. Women who are recently menopausal (50-60 yrs. of age) and over 20 years postmenopausal (\>70 yrs. of age) will take estrogen or placebo for three months. At the end of that time they will participate in three challenges using dietary techniques to briefly change the relative amounts of neurotransmitters in the brain that are believed to be related to mood regulation (serotonin, dopamine, and norepinephrine). Previous research has shown that these dietary manipulations can briefly produce negative changes in mood. The investigator hypothesizes that estrogen administration will blunt or buffer these negative effects in a quantifiable way. The investigator believes that this will provide a direct test of the ability of estrogen to meaningfully change the brain chemistry of mood in a clinically measurable and positive way. The proposed procedure will also allow assessment of the effects of estrogen on brain neurotransmitter systems after many years of very low estrogen levels.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
June 1, 2000
CompletedFirst Posted
Study publicly available on registry
June 2, 2000
CompletedJune 24, 2005
December 1, 2003
June 1, 2000
June 23, 2005
Conditions
Interventions
Eligibility Criteria
You may qualify if:
- Postmenopausal
- Non-smoker
- BMI \<30
- Healthy
- Without surgically-induced menopause
- Not on HRT or \>1 year post HRT
- Normal mammogram within last year
- No cardiovascular disease other than mild hypertension
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University of Vermont
Burlington, Vermont, 05401, United States
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- phase 2
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Purpose
- TREATMENT
- Sponsor Type
- NIH
Study Record Dates
First Submitted
June 1, 2000
First Posted
June 2, 2000
Last Updated
June 24, 2005
Record last verified: 2003-12